NEUROLOGY
SURGERY
|
Question
[CLICK ON ANY CHOICE TO KNOW THE RIGHT ANSWER]
|
A patient with end-stage kidney disease(ESKD) is taking recombinant erythropoietin for the treatment of anemia. Which laboratory study will be obtained at least monthly related to this medication?
|
|
Potassium level
|
|
|
Creatinine level
|
|
|
Hemoglobin level
|
|
|
Folate levels
|
Explanation:
Detailed explanation-1: -EPO tells your body to make red blood cells. When you have kidney disease, your kidneys cannot make enough EPO. Low EPO levels cause your red blood cell count to drop and anemia to develop. Most people with kidney disease will develop anemia.
Detailed explanation-2: -Your health care professional may prescribe an erythropoiesis-stimulating agent (ESA) to treat your anemia. ESAs send a signal to your bone marrow to make more red blood cells. If you’re on hemodialysis, you may receive IV or subcutaneous ESAs during your dialysis treatments.
There is 1 question to complete.